Key result
Routine monitoring of the anticoagulant effect of direct oral anticoagulants like rivaroxaban is not yet well-defined, but may be useful in specific situations such as extremely high bleeding risk.
Routine monitoring of DOACs is not well-defined but may be beneficial in specific high-risk situations such as extreme bleeding risk or prior to thrombolytic therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Camanho et al. (2021) conducted an editorial in Atrial Fibrillation. Rivaroxaban was evaluated. Routine monitoring of the anticoagulant effect of direct oral anticoagulants like rivaroxaban is not yet well-defined, but may be useful in specific situations such as extremely high bleeding risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: